Anti-HER2 scFv antibody-directed lentiviral delivery of myrosinase for eradicating HER2+cancer cells after dosing prodrug sinigrin

被引：0
|
作者：
Tarar, Ammar Ahmad [1 ]
Peng, Ching-An [1 ]
机构：
[1] Univ Idaho, Moscow, ID 83843 USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3291
引用
收藏
页数：1
相关论文
共 50 条
  • [31] A Conjugate Based on Anti-HER2 Diaffibody and Auristatin E Targets HER2-Positive Cancer Cells
    Serwotka-Suszczak, Anna M.
    Sochaj-Gregorczyk, Alicja M.
    Pieczykolan, Jerzy
    Krowarsch, Daniel
    Jelen, Filip
    Otlewski, Jacek
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (02)
  • [32] Anti-HER2 antibody enhances the growth inhibitory effect of anti-oestrogen on breast cancer cells expressing both oestrogen receptors and HER2
    Kunisue, H
    Kurebayashi, J
    Otsuki, T
    Tang, CK
    Kurosumi, M
    Yamamoto, S
    Tanaka, K
    Doihara, H
    Shimizu, N
    Sonoo, H
    BRITISH JOURNAL OF CANCER, 2000, 82 (01) : 46 - 51
  • [33] Antitumor effects of a recombinant baculovirus displaying anti-HER2 scFv expressing Apoptin in HER2 positive SK-BR-3 breast cancer cells
    Meysami, Parisa
    Rezaei, Farhad
    Marashi, Sayed Mahdi
    Amiri, Mohammad Mehdi
    Bakker, Emyr
    Mokhtari-Azad, Talat
    FUTURE VIROLOGY, 2019, 14 (03) : 139 - 152
  • [34] Lung toxicity induced by anti-HER2 antibody - drug conjugates for breast cancer
    Chai, Mengting
    Li, Li
    Wu, Huachao
    Liu, Yue
    Yi, Zongbi
    Yu, Haijun
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2024, 195
  • [35] Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer
    Shak, S
    SEMINARS IN ONCOLOGY, 1999, 26 (04) : 71 - 77
  • [36] Neural Stem Cells Secreting Anti-HER2 Antibody Improve Survival in a Preclinical Model of HER2 Overexpressing Breast Cancer Brain Metastases
    Kanojia, Deepak
    Balyasnikova, Irina V.
    Morshed, Ramin A.
    Frank, Richard T.
    Yu, Dou
    Zhang, Lingjiao
    Spencer, Drew A.
    Kim, Julius W.
    Han, Yu
    Yu, Dihua
    Ahmed, Atique U.
    Aboody, Karen S.
    Lesniak, Maciej S.
    STEM CELLS, 2015, 33 (10) : 2985 - 2994
  • [37] An anti-HER2 antibody conjugated with monomethyl auristatin E is highly effective in HER2-positive human gastric cancer
    Li, Hongwen
    Yu, Chao
    Jiang, Jing
    Huang, Changjiang
    Yao, Xuejing
    Xu, Qiaoyu
    Yu, Fang
    Lou, Liguang
    Fang, Jianmin
    CANCER BIOLOGY & THERAPY, 2016, 17 (04) : 346 - 354
  • [38] Construction of Anti-HER2 Recombinants as Targeting Modules for a Drug-delivery System Against HER2-positive Cells
    Tang, Qing
    Onitsuka, Masayoshi
    Tabata, Atsushi
    Tomoyasu, Toshifumi
    Nagamune, Hideaki
    ANTICANCER RESEARCH, 2018, 38 (07) : 4319 - 4325
  • [39] Trastuzumab (Herceptin), a humanized anti-HER2 receptor monoclonal antibody, inhibits basal and activated HER2 ectodomain cleavage in breast cancer cells
    Molina, MA
    Codony-Servat, J
    Albanell, J
    Rojo, F
    Arribas, J
    Baselga, J
    CANCER RESEARCH, 2001, 61 (12) : 4744 - 4749
  • [40] Targeting HER2+breast cancer cells: Lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticles
    Owen, Shawn C.
    Patel, Nish
    Logie, Jennifer
    Pan, Guohua
    Persson, Helena
    Moffat, Jason
    Sidhu, Sachdev S.
    Shoichet, Molly S.
    JOURNAL OF CONTROLLED RELEASE, 2013, 172 (02) : 395 - 404
12345